TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hikal Limited ( (IN:HIKAL) ) just unveiled an announcement.
Hikal Limited has announced a Scheme of Amalgamation involving its promoter group companies, which has been approved by the Regional Director, Ministry of Corporate Affairs. The scheme involves the amalgamation of Shri Rameshwara Investment Private Limited and Shri Badrinath Investment Private Limited into Castilia Life Sciences Private Limited, resulting in the transfer of shares held by the former two companies to Castilia. This restructuring is expected to streamline the company’s promoter group structure, potentially enhancing operational efficiencies and shareholder value.
More about Hikal Limited
Hikal Limited operates in the life sciences and chemicals industry, providing a range of products and services primarily focused on pharmaceuticals, crop protection, and specialty chemicals. The company is known for its integrated offerings and has a significant market presence in these sectors.
Average Trading Volume: 30,327
Technical Sentiment Signal: Sell
Current Market Cap: 27.84B INR
For a thorough assessment of HIKAL stock, go to TipRanks’ Stock Analysis page.